Two Biotech Firms And Their Co-Founder To Pay $10 Million To Resolve Allegations Of Mischarging Federal Grants
SAN FRANCISCO – Two biotechnology companies and their co-founder will pay more than $10 million to the United States to resolve allegations under the False Claims Act that they engaged in improper billing to federal grants, announced United States Attorney Stephanie M. Hinds, Special Agent in Charge Steven J. Ryan of the Department of Health and Human Services Office of Inspector General (HHS-OIG), Special Agent in Charge L. Scott Moreland of the Major Procurement Fraud Field Office of the Department of the Army Criminal Investigation Division (Army CID), and Special Agent in Charge Bryan Denny of the Western Field Office of the Department of Defense Office of Inspector General, Defense Criminal Investigative Service (DCIS).
Action Details
- Date:December 21, 2022
- Agency:California Attorney General
-
Enforcement Types:
- State Enforcement Agencies